These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 29338150)

  • 21. Challenges and Opportunities in Preclinical Research of Synthetic Cannabinoids for Pain Therapy.
    Tamba BI; Stanciu GD; Urîtu CM; Rezus E; Stefanescu R; Mihai CT; Luca A; Rusu-Zota G; Leon-Constantin MM; Cojocaru E; Gafton B; Alexa-Stratulat T
    Medicina (Kaunas); 2020 Jan; 56(1):. PubMed ID: 31936616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonopioid medications for pain.
    Tauben D
    Phys Med Rehabil Clin N Am; 2015 May; 26(2):219-48. PubMed ID: 25952062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic pain and cannabinoids. Great expectations or a christmas carol.
    Pascual D; Sánchez-Robles EM; García MM; Goicoechea C
    Biochem Pharmacol; 2018 Nov; 157():33-42. PubMed ID: 30056139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Use of cannabinoids in palliative medicine].
    Ernst G; Kongsgaard UE
    Tidsskr Nor Laegeforen; 2008 Apr; 128(7):822-5. PubMed ID: 18389029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review.
    Hill KP
    JAMA; 2015 Jun 23-30; 313(24):2474-83. PubMed ID: 26103031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy.
    Rice AS; Farquhar-Smith WP; Nagy I
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):243-56. PubMed ID: 12052040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and adverse effects of medical marijuana for chronic noncancer pain: Systematic review of randomized controlled trials.
    Deshpande A; Mailis-Gagnon A; Zoheiry N; Lakha SF
    Can Fam Physician; 2015 Aug; 61(8):e372-81. PubMed ID: 26505059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational studies.
    Stockings E; Campbell G; Hall WD; Nielsen S; Zagic D; Rahman R; Murnion B; Farrell M; Weier M; Degenhardt L
    Pain; 2018 Oct; 159(10):1932-1954. PubMed ID: 29847469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science.
    Baron EP
    Headache; 2018 Jul; 58(7):1139-1186. PubMed ID: 30152161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reassessment of the role of cannabinoids in the management of pain.
    Beaulieu P; Ware M
    Curr Opin Anaesthesiol; 2007 Oct; 20(5):473-7. PubMed ID: 17873600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabinoids for Treatment of MS Symptoms: State of the Evidence.
    Rice J; Cameron M
    Curr Neurol Neurosci Rep; 2018 Jun; 18(8):50. PubMed ID: 29923025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Role of Organic Small Molecules in Pain Management.
    Cuesta SA; Meneses L
    Molecules; 2021 Jul; 26(13):. PubMed ID: 34279369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabinoids in the Orthopedic Setting: A Literature Review.
    Carreira DS; Garden S; Huffman A; Ueland T
    Orthopedics; 2022; 45(4):e183-e189. PubMed ID: 35245146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complexity of pain management among patients with nociceptive or neuropathic neck, back, or osteoarthritis diagnoses.
    Kozma CM; Provenzano DA; Slaton TL; Patel AA; Benson CJ
    J Manag Care Spec Pharm; 2014 May; 20(5):455-66b. PubMed ID: 24761817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cannabinoids: Medical implications.
    Schrot RJ; Hubbard JR
    Ann Med; 2016; 48(3):128-41. PubMed ID: 26912385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent developments in the therapeutic potential of cannabinoids.
    Corey S
    P R Health Sci J; 2005 Mar; 24(1):19-26. PubMed ID: 15895873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabinoids and autoimmune diseases: A systematic review.
    Katchan V; David P; Shoenfeld Y
    Autoimmun Rev; 2016 Jun; 15(6):513-28. PubMed ID: 26876387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain.
    Iskedjian M; Bereza B; Gordon A; Piwko C; Einarson TR
    Curr Med Res Opin; 2007 Jan; 23(1):17-24. PubMed ID: 17257464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabinoids and pain.
    Walker JM; Strangman NM; Huang SM
    Pain Res Manag; 2001; 6(2):74-9. PubMed ID: 11854769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An overview of the cannabinoid type 2 receptor system and its therapeutic potential.
    Bie B; Wu J; Foss JF; Naguib M
    Curr Opin Anaesthesiol; 2018 Aug; 31(4):407-414. PubMed ID: 29794855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.